CreditReports.dk
HomeScreen companies

PHARMA-TECH A/S Financials, key figures and credit report

CVR number: 32940897 Established 2010 Industry: 22 Manufacture of rubber and plastic products
Company contact details
Messingvej 23, 8940 Randers SV mail@pharma-tech.dk tel: 86481166
Gross profit 32 243.3 kDKK FY 2025 +18.3% vs 2024
EBIT 7 850.1 kDKK FY 2025 -14% vs 2024
Net debt 15 143.5 kDKK FY 2025 -15.1% vs 2024
Quick ratio 1.2 FY 2025 +0.4 vs 2024

Company information

Official name
PHARMA-TECH A/S
Personnel
41 persons
Established
2010
Company form
Limited company
Industry

Data sources and methodology

The information about PHARMA-TECH A/S combines official Danish company and financial-statement data with indicators calculated by Valuatum Oy.

Company information

Name, CVR number, address, industry and legal form are based on the Danish Central Business Register (CVR).

CVR / Virk

Annual accounts

Financial figures come from annual reports published through the Danish Business Authority. The latest financial year used is 2025.

Open the 2025 annual report

Key figures and credit risk

Valuatum Oy calculates financial ratios, comparisons and credit-risk indicators from the available accounts. The results support analysis and do not constitute a standalone credit decision.

Valuatum Oy

About PHARMA-TECH A/S

PHARMA-TECH A/S (CVR number: 3294089-7) is a company from RANDERS. The company recorded a gross profit of 32.2 mDKK in 2025. The operating profit was 7850.1 kDKK, while net earnings were 5636.9 kDKK. The profitability of the company measured by Return on Assets (ROA) was 17.3 %, which can be considered excellent and Return on Equity (ROE) was 23.8 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 53.3 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. PHARMA-TECH A/S's liquidity measured by quick ratio was 1.2 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.

Financial information

See financials

Gross profit (kDKK)

EBIT (kDKK)

Profitability

Solidity

Key figures (kDKK)

See financials
2021
2022
2023
2024
2025
Volume
Net sales
Gross profit18 037.7919 733.4224 106.5927 253.7332 243.34
EBIT4 160.605 761.698 565.809 123.517 850.14
Net earnings3 111.044 335.936 453.106 599.235 636.89
Shareholders equity total17 431.4319 767.3524 220.4522 819.6924 456.58
Balance sheet total (assets)28 659.7429 471.3440 568.3345 874.9145 921.70
Net debt5 284.541 548.52-1 621.4517 835.3215 143.51
Profitability
EBIT-%
ROA14.1 %19.8 %24.5 %21.1 %17.3 %
ROE15.7 %23.3 %29.3 %28.1 %23.8 %
ROI16.8 %22.7 %29.9 %25.4 %19.6 %
Economic value added (EVA)1 998.323 250.635 365.065 530.824 198.78
Solvency
Equity ratio60.8 %67.1 %59.7 %49.7 %53.3 %
Gearing31.7 %13.0 %0.1 %78.2 %63.7 %
Relative net indebtedness %
Liquidity
Quick ratio0.61.21.30.81.2
Current ratio1.52.52.11.52.3
Cash and cash equivalents234.661 015.981 639.9519.69440.40
Capital use efficiency
Trade debtors turnover (days)
Net working capital %

Variable visualization

ROA FY 2025
17.3%
Rating 70/100
-20%
0%
4%
11%
24%
60%
Graph showing the distribution of the variable
Equity ratio FY 2025
53.3%
Rating 42/100
-1%
21%
50%
81%
99%
100%
Graph showing the distribution of the variable

Credit Risk Report

Affordable credit risk report
for basic company risk checks.

Check the creditworthiness of PHARMA-TECH A/S before offering payment terms. The report combines financial figures, risk scores, credit rating, bankruptcy risk and a credit-limit recommendation in one PDF.

AI Credit Risk Report

The core credit-risk figures,
explained with AI.

The AI Credit Risk Report contains the same core financial figures and risk measures as the Credit Risk Report. It also provides written analysis of the company's finances, risks, repayment capacity and assets, together with relevant context from web searches.

  1. 01 Includes the same financial figures, risk scores, credit rating and bankruptcy risk as the Credit Risk Report.
  2. 02 AI complements the analysis with web searches and brings in the relevant company and operating-environment observations.
  3. 03 The written analysis is more precise, more readable and better suited to decision-making.
€3 / report

Company-specific, AI-assisted credit risk report in PDF format.

For larger customers

Reports can be tailored to your own credit process: content structure, peer groups, risk thresholds, delivery method and AI-analysis weightings can all be adapted to your needs.
Ask about a tailored solution: contact@creditreports.dk

The report is intended for an initial financial assessment. · The final credit decision and any further verification are always the user's responsibility. · One-time payment, no subscription.

What the report includes

8 sections
Financial figures
Risk scores
Credit rating
Bankruptcy risk
AI web-search highlights
Written risk analysis
Conclusions
Ratio appendices

Roles

Companies in the same industry

Page generated